ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Some studies [18, 23] have shown that hepatic adiponectin sensitivity and resistance mediated by adiponectin/AdipoR signaling play a vital role in the pathogenesis of NAFLD.